United States Dry Eye Syndrome Drugs Market Report & Forecast 2021-2027

United States Dry Eye Syndrome Drugs Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Dry Eye Syndrome Drugs Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Dry Eye Syndrome Drugs Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Dry Eye Syndrome Drugs Overall Market Size
2.1 United States Dry Eye Syndrome Drugs Market Size: 2021 VS 2027
2.2 United States Dry Eye Syndrome Drugs Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Dry Eye Syndrome Drugs Players in United States Market
3.2 Top United States Dry Eye Syndrome Drugs Companies Ranked by Revenue
3.3 United States Dry Eye Syndrome Drugs Revenue by Companies
3.4 Top 3 and Top 5 Dry Eye Syndrome Drugs Companies in United States Market, by Revenue in 2020
3.5 Companies Dry Eye Syndrome Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Dry Eye Syndrome Drugs Players in United States Market
3.6.1 List of Tier 1 Dry Eye Syndrome Drugs Companies in United States
3.6.2 List of Tier 2 and Tier 3 Dry Eye Syndrome Drugs Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Dry Eye Syndrome Drugs Market Size Markets, 2021 & 2027
4.1.2 Antibiotic Drops
4.1.3 Hormone Drops
4.1.4 Artificial Tears
4.2 By Type - United States Dry Eye Syndrome Drugs Revenue & Forecasts
4.2.1 By Type - United States Dry Eye Syndrome Drugs Revenue, 2016-2021
4.2.2 By Type - United States Dry Eye Syndrome Drugs Revenue, 2022-2027
4.2.3 By Type - United States Dry Eye Syndrome Drugs Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Dry Eye Syndrome Drugs Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Household Use
5.2 By Application - United States Dry Eye Syndrome Drugs Revenue & Forecasts
5.2.1 By Application - United States Dry Eye Syndrome Drugs Revenue, 2016-2021
5.2.2 By Application - United States Dry Eye Syndrome Drugs Revenue, 2022-2027
5.2.3 By Application - United States Dry Eye Syndrome Drugs Revenue Market Share, 2016-2027
6 Dry Eye Syndrome Drugs Companies Profiles
6.1 Allergan
6.1.1 Allergan Company Details
6.1.2 Allergan Business Overview
6.1.3 Allergan Dry Eye Syndrome Drugs Introduction
6.1.4 Allergan Dry Eye Syndrome Drugs Revenue in United States Market (2016-2021)
6.1.5 Allergan Recent Developments
6.2 Novartis
6.2.1 Novartis Company Details
6.2.2 Novartis Business Overview
6.2.3 Novartis Dry Eye Syndrome Drugs Introduction
6.2.4 Novartis Dry Eye Syndrome Drugs Revenue in United States Market (2016-2021)
6.2.5 Novartis Recent Developments
6.3 Santen
6.3.1 Santen Company Details
6.3.2 Santen Business Overview
6.3.3 Santen Dry Eye Syndrome Drugs Introduction
6.3.4 Santen Dry Eye Syndrome Drugs Revenue in United States Market (2016-2021)
6.3.5 Santen Recent Developments
6.4 Takeda
6.4.1 Takeda Company Details
6.4.2 Takeda Business Overview
6.4.3 Takeda Dry Eye Syndrome Drugs Introduction
6.4.4 Takeda Dry Eye Syndrome Drugs Revenue in United States Market (2016-2021)
6.4.5 Takeda Recent Developments
6.5 Otsuka
6.5.1 Otsuka Company Details
6.5.2 Otsuka Business Overview
6.5.3 Otsuka Dry Eye Syndrome Drugs Introduction
6.5.4 Otsuka Dry Eye Syndrome Drugs Revenue in United States Market (2016-2021)
6.5.5 Otsuka Recent Developments
6.6 Eyegate Pharma
6.6.1 Eyegate Pharma Company Details
6.6.2 Eyegate Pharma Business Overview
6.6.3 Eyegate Pharma Dry Eye Syndrome Drugs Introduction
6.6.4 Eyegate Pharma Dry Eye Syndrome Drugs Revenue in United States Market (2016-2021)
6.6.5 Eyegate Pharma Recent Developments
6.7 Can-Fite BioPharma
6.7.1 Can-Fite BioPharma Company Details
6.7.2 Can-Fite BioPharma Business Overview
6.7.3 Can-Fite BioPharma Dry Eye Syndrome Drugs Introduction
6.7.4 Can-Fite BioPharma Dry Eye Syndrome Drugs Revenue in United States Market (2016-2021)
6.7.5 Can-Fite BioPharma Recent Developments
6.8 Bausch and Lomb
6.8.1 Bausch and Lomb Company Details
6.8.2 Bausch and Lomb Business Overview
6.8.3 Bausch and Lomb Dry Eye Syndrome Drugs Introduction
6.8.4 Bausch and Lomb Dry Eye Syndrome Drugs Revenue in United States Market (2016-2021)
6.8.5 Bausch and Lomb Recent Developments
6.9 Auven Therapeutics (Celtic)
6.9.1 Auven Therapeutics (Celtic) Company Details
6.9.2 Auven Therapeutics (Celtic) Business Overview
6.9.3 Auven Therapeutics (Celtic) Dry Eye Syndrome Drugs Introduction
6.9.4 Auven Therapeutics (Celtic) Dry Eye Syndrome Drugs Revenue in United States Market (2016-2021)
6.9.5 Auven Therapeutics (Celtic) Recent Developments
6.10 Bridge Pharma
6.10.1 Bridge Pharma Company Details
6.10.2 Bridge Pharma Business Overview
6.10.3 Bridge Pharma Dry Eye Syndrome Drugs Introduction
6.10.4 Bridge Pharma Dry Eye Syndrome Drugs Revenue in United States Market (2016-2021)
6.10.5 Bridge Pharma Recent Developments
6.11 Cellzome
6.11.1 Cellzome Company Details
6.11.2 Cellzome Business Overview
6.11.3 Cellzome Dry Eye Syndrome Drugs Introduction
6.11.4 Cellzome Dry Eye Syndrome Drugs Revenue in United States Market (2016-2021)
6.11.5 Cellzome Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
Table 1. Dry Eye Syndrome Drugs Market Opportunities & Trends in United States Market
Table 2. Dry Eye Syndrome Drugs Market Drivers in United States Market
Table 3. Dry Eye Syndrome Drugs Market Restraints in United States Market
Table 4. Key Players of Dry Eye Syndrome Drugs in United States Market
Table 5. Top Dry Eye Syndrome Drugs Players in United States Market, Ranking by Revenue (2019)
Table 6. United States Dry Eye Syndrome Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 7. United States Dry Eye Syndrome Drugs Revenue Share by Companies, 2016-2021
Table 8. Companies Dry Eye Syndrome Drugs Product Type
Table 9. List of Tier 1 Dry Eye Syndrome Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Dry Eye Syndrome Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - United States Dry Eye Syndrome Drugs Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - United States Dry Eye Syndrome Drugs Revenue (US$, Mn), 2016-2021
Table 13. By Type - United States Dry Eye Syndrome Drugs Revenue (US$, Mn), 2022-2027
Table 14. By Application - United States Dry Eye Syndrome Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - United States Dry Eye Syndrome Drugs Revenue (US$, Mn), 2016-2021
Table 16. By Application - United States Dry Eye Syndrome Drugs Revenue (US$, Mn), 2022-2027
Table 17. Allergan Company Details
Table 18. Allergan Business Overview
Table 19. Allergan Dry Eye Syndrome Drugs Product
Table 20. Allergan Dry Eye Syndrome Drugs Revenue in United States Market (2016-2021) & (US$ Million)
Table 21. Allergan Recent Developments
Table 22. Novartis Company Details
Table 23. Novartis Business Overview
Table 24. Novartis Dry Eye Syndrome Drugs Product
Table 25. Novartis Dry Eye Syndrome Drugs Revenue in United States Market (2016-2021) & (US$ Million)
Table 26. Novartis Recent Developments
Table 27. Santen Company Details
Table 28. Santen Business Overview
Table 29. Santen Dry Eye Syndrome Drugs Product
Table 30. Santen Dry Eye Syndrome Drugs Revenue in United States Market (2016-2021) & (US$ Million)
Table 31. Santen Recent Developments
Table 32. Takeda Company Details
Table 33. Takeda Business Overview
Table 34. Takeda Dry Eye Syndrome Drugs Product
Table 35. Takeda Dry Eye Syndrome Drugs Revenue in United States Market (2016-2021) & (US$ Million)
Table 36. Takeda Recent Developments
Table 37. Otsuka Company Details
Table 38. Otsuka Business Overview
Table 39. Otsuka Dry Eye Syndrome Drugs Product
Table 40. Otsuka Dry Eye Syndrome Drugs Revenue in United States Market (2016-2021) & (US$ Million)
Table 41. Otsuka Recent Developments
Table 42. Eyegate Pharma Company Details
Table 43. Eyegate Pharma Business Overview
Table 44. Eyegate Pharma Dry Eye Syndrome Drugs Product
Table 45. Eyegate Pharma Dry Eye Syndrome Drugs Revenue in United States Market (2016-2021) & (US$ Million)
Table 46. Eyegate Pharma Recent Developments
Table 47. Can-Fite BioPharma Company Details
Table 48. Can-Fite BioPharma Business Overview
Table 49. Can-Fite BioPharma Dry Eye Syndrome Drugs Product
Table 50. Can-Fite BioPharma Dry Eye Syndrome Drugs Revenue in United States Market (2016-2021) & (US$ Million)
Table 51. Can-Fite BioPharma Recent Developments
Table 52. Bausch and Lomb Company Details
Table 53. Bausch and Lomb Business Overview
Table 54. Bausch and Lomb Dry Eye Syndrome Drugs Product
Table 55. Bausch and Lomb Dry Eye Syndrome Drugs Revenue in United States Market (2016-2021) & (US$ Million)
Table 56. Bausch and Lomb Recent Developments
Table 57. Auven Therapeutics (Celtic) Company Details
Table 58. Auven Therapeutics (Celtic) Business Overview
Table 59. Auven Therapeutics (Celtic) Dry Eye Syndrome Drugs Product
Table 60. Auven Therapeutics (Celtic) Dry Eye Syndrome Drugs Revenue in United States Market (2016-2021) & (US$ Million)
Table 61. Auven Therapeutics (Celtic) Recent Developments
Table 62. Bridge Pharma Company Details
Table 63. Bridge Pharma Business Overview
Table 64. Bridge Pharma Dry Eye Syndrome Drugs Product
Table 65. Bridge Pharma Dry Eye Syndrome Drugs Revenue in United States Market (2016-2021) & (US$ Million)
Table 66. Bridge Pharma Recent Developments
Table 67. Cellzome Company Details
Table 68. Cellzome Business Overview
Table 69. Cellzome Dry Eye Syndrome Drugs Product
Table 70. Cellzome Dry Eye Syndrome Drugs Revenue in United States Market (2016-2021) & (US$ Million)
Table 71. Cellzome Recent Developments
List of Figures
Figure 1. Dry Eye Syndrome Drugs Segment by Type
Figure 2. Dry Eye Syndrome Drugs Segment by Application
Figure 3. United States Dry Eye Syndrome Drugs Market Overview: 2020
Figure 4. United States Dry Eye Syndrome Drugs Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. United States Dry Eye Syndrome Drugs Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Dry Eye Syndrome Drugs Revenue in 2020
Figure 7. By Type - United States Dry Eye Syndrome Drugs Revenue Market Share, 2016-2027
Figure 8. By Application - United States Dry Eye Syndrome Drugs Revenue Market Share, 2016-2027
Figure 9. Allergan Dry Eye Syndrome Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Novartis Dry Eye Syndrome Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Santen Dry Eye Syndrome Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Takeda Dry Eye Syndrome Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Otsuka Dry Eye Syndrome Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Eyegate Pharma Dry Eye Syndrome Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Can-Fite BioPharma Dry Eye Syndrome Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Bausch and Lomb Dry Eye Syndrome Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. Auven Therapeutics (Celtic) Dry Eye Syndrome Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 18. Bridge Pharma Dry Eye Syndrome Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 19. Cellzome Dry Eye Syndrome Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Artificial Tears Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 91

Artificial tears are lubricant eye drops used to treat The dryness and irritation associated with deficient tear production in keratoconjunctivitis sicca (dry eyes). They are also used to moisten contact lenses and in eye examinations. The global Artificial Tears market was valued at US$ 2921.6 million in 2023 and is anticipated to reach US$ 5240.1 million by 2030, witnessing a CAGR of 8.6% during The forecast period 2024-2030. The industry's leading producers are Aller......

Global Contact Lens Solution Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 96

Contact lens solution is a kind of solution that is used to contact lens with The function of cleaning, disinfection, rinsing or preservation, it can also alleviate The eyeball discomfort which caused by wear The contact lens. Contact lens solution can direct contact eyeball, so it must be accord with industrial standard. The global Contact Lens Solution market was valued at US$ 4087.6 million in 2023 and is anticipated to reach US$ 5323.5 million by 2030, witnessing a CAGR of 3.8% ......

Global Latanoprost Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 82

Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside The eye. Onset of effects is usually within four hours, and they last for up to a day. Latanoprost is used to treat high pressure inside The eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in The body (prostaglandin) and works by regulating The flow of fluid within The eye which results in lower pressure. Lowerin......

Global Contact Lens Solution Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 99

Market Overview of Global Contact Lens Solution market: According to our latest research, the global Contact Lens Solution market looks promising in the next 5 years. As of 2022, the global Contact Lens Solution market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Contact ......

Global Dry Eye Syndrome Drugs Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 82

The Dry Eye Syndrome Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dry Eye Syndrome Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive......

Global Eye Drops & Lubricants Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 112

According to our LPI (LP Information) latest study, the global Eye Drops & Lubricants market size was valued at US$ 8841.8 million in 2023. With growing demand in downstream market, the Eye Drops & Lubricants is forecast to a readjusted size of US$ 9780.8 million by 2030 with a CAGR of 1.5% during review period. The research report highlights the growth potential of the global Eye Drops & Lubricants market. Eye Drops & Lubricants are expected to show stable growth in the future market. H......

Global Conjunctivitis Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 98

According to our LPI (LP Information) latest study, the global Conjunctivitis market size was valued at US$ 3482.7 million in 2023. With growing demand in downstream market, the Conjunctivitis is forecast to a readjusted size of US$ 3908 million by 2030 with a CAGR of 1.7% during review period. The research report highlights the growth potential of the global Conjunctivitis market. Conjunctivitis are expected to show stable growth in the future market. However, product differentiation, r......

Global Contact Lens Solution Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 118

According to our LPI (LP Information) latest study, the global Contact Lens Solution market size was valued at US$ 3998.7 million in 2023. With growing demand in downstream market, the Contact Lens Solution is forecast to a readjusted size of US$ 5241.5 million by 2030 with a CAGR of 3.9% during review period. The research report highlights the growth potential of the global Contact Lens Solution market. Contact Lens Solution are expected to show stable growth in the future market. Howev......

Global Latanoprost Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90

According to our LPI (LP Information) latest study, the global Latanoprost market size was valued at US$ 1344.2 million in 2023. With growing demand in downstream market, the Latanoprost is forecast to a readjusted size of US$ 1574.2 million by 2030 with a CAGR of 2.3% during review period. The research report highlights the growth potential of the global Latanoprost market. Latanoprost are expected to show stable growth in the future market. However, product differentiation, reducing co......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs